UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549
                                  SCHEDULE l3D
                    Under the Securities Exchange Act of 1934
                               (Amendment No. 7)*


                            KINDRED HEALTHCARE, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, par value $0.25 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    494580103
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                                     with a copy to:
       Stephen Feinberg                              Robert G. Minion, Esq.
       299 Park Avenue                               Lowenstein Sandler PC
       22nd Floor                                    65 Livingston Avenue
       New York, New York  10171                     Roseland, New Jersey  07068
       (212) 421-2600                                (973) 597-2424
--------------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                December 18, 2003
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule l3G to report
the  acquisition  that is the subject of this  Schedule 13D, and is filing  this
schedule because of Sections 240.13d-1(e),  240.13d-1(f) or 240.13d-1(g),  check
the following box.  [  ]

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits.  See Section 240.13d-7 for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).





Cusip No. 494580103
--------------------------------------------------------------------------------
  1)   Names of  Reporting Persons.  I.R.S. Identification Nos. of above persons
       (entities only):

                                Stephen Feinberg
--------------------------------------------------------------------------------
  2)   Check the Appropriate Box  if a Member of a Group  (See Instructions):
             (a)              Not
             (b)           Applicable

--------------------------------------------------------------------------------
  3)   SEC Use Only

--------------------------------------------------------------------------------
  4)   Source of Funds (See Instructions):    WC

--------------------------------------------------------------------------------
  5)   Check if  Disclosure of  Legal Proceedings is  Required Pursuant to Items
       2(d) or 2(e):           Not Applicable

--------------------------------------------------------------------------------
  6)   Citizenship or Place of Organization:     United States

--------------------------------------------------------------------------------
        Number of                        7) Sole Voting Power:            *
                                            ------------------------------------
        Shares Beneficially              8) Shared Voting Power:          *
                                            ------------------------------------
        Owned by
        Each Reporting                   9) Sole Dispositive Power:       *
                                            ------------------------------------
        Person With                     10) Shared Dispositive Power:     *
                                            ------------------------------------
--------------------------------------------------------------------------------
  11)  Aggregate Amount Beneficially Owned by Each Reporting Person:  1,240,000*

--------------------------------------------------------------------------------
  12)  Check if the  Aggregate Amount in Row (11)  Excludes Certain Shares  (See
       Instructions):        Not Applicable

--------------------------------------------------------------------------------
  13)  Percent of Class Represented by Amount in Row (11):      6.9%*

--------------------------------------------------------------------------------
  14)  Type of Reporting Person (See Instructions):     IA, IN

--------------------------------------------------------------------------------
*   Cerberus Partners, L.P., a Delaware limited partnership ("Cerberus"), is the
holder of 15,570  shares of the  common  stock,  par value  $0.25 per share (the
"Shares"), of Kindred Healthcare,  Inc. (the "Company"),  Cerberus Institutional
Partners, L.P., a Delaware limited partnership ("Institutional"),  is the holder
of 225,349 Shares, Cerberus  International,  Ltd., a corporation organized under
the laws of the Bahamas  ("International"),  is the holder of 666,400 Shares and
various  other  private  investment  funds (the  "Funds")  own in the  aggregate
332,681  Shares.  Stephen  Feinberg  possesses sole power to vote and direct the
disposition  of all  securities  of the  Company  owned  by  each  of  Cerberus,
Institutional,  International  and the Funds.  Thus,  for the  purposes  of Reg.
Section  240.13d-3,  Stephen  Feinberg is deemed to  beneficially  own 1,240,000
Shares,  or 6.9% of those  deemed  issued  and  outstanding.  See Item 5 of this
Amendment No. 7 to Schedule 13D for further information.





Item 5.   Interest in Securities of the Issuer.
          ------------------------------------

          Based  upon  the  Company's  Quarterly  Report  on Form  10-Q  for the
quarterly  period ended  September  30, 2003,  as of October 31, 2003 there were
17,923,929 Shares issued and outstanding.  As of December 18, 2003,  Cerberus is
the holder of 15,570  Shares,  Institutional  is the  holder of 225,349  Shares,
International  is the  holder of 666,400  Shares and the Funds in the  aggregate
hold 332,681 Shares.  Mr.  Feinberg  possesses sole power to vote and direct the
disposition  of all  securities  of the  Company  owned  by  each  of  Cerberus,
Institutional,  International  and the Funds.  Thus,  for the  purposes  of Reg.
Section  240.13d-3,  Stephen  Feinberg is deemed to  beneficially  own 1,240,000
Shares, or 6.9% of those deemed issued and outstanding.

          The following table details the transactions effected during the sixty
days prior to  December  18, 2003 in Shares,  or  securities  convertible  into,
exercisable for or exchangeable for Shares,  by Mr. Feinberg or any other person
or entity  controlled  by him or any  person or  entity  for which he  possesses
voting or  investment  control over the  securities  thereof (each of which were
effected in an ordinary brokerage transaction):


                                   I. Cerberus
                                   -----------

                                   (Purchases)

                                      NONE


                                     (Sales)

        Date                        Quantity                     Price
        ----                        --------                     -----

   October 20, 2003                     825                      $39.58
   December 15, 2003                    400                      $51.13
   December 18, 2003                    300                      $51.00



                                II. Institutional
                                -----------------

                                   (Purchases)

                                      NONE


                                     (Sales)

        Date                        Quantity                     Price
        ----                        --------                     -----

   October 20, 2003                  11,975                      $39.58
   December 15, 2003                  6,350                      $51.13
   December 18, 2003                  4,600                      $51.00






                               III. International
                               ------------------

                                   (Purchases)

                                      NONE


                                     (Sales)

        Date                        Quantity                     Price
        ----                        --------                     -----

   October 20, 2003                  35,415                      $39.58
   December 15, 2003                 18,800                      $51.13
   December 18, 2003                 13,400                      $51.00



                                  IV. The Funds
                                  -------------

                                   (Purchases)

                                      NONE


                                     (Sales)

        Date                        Quantity                     Price
        ----                        --------                     -----

   October 20, 2003                  17,685                      $39.58
   December 15, 2003                  9,450                      $51.13
   December 18, 2003                  6,700                      $51.00







                                    Signature

            After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.

                                          December 22, 2003


                                          /s/ Stephen Feinberg
                                          --------------------------------------
                                          Stephen  Feinberg,  in   his  capacity
                                          as  the  managing  member of  Cerberus
                                          Associates,   L.L.C.,    the   general
                                          partner of  Cerberus  Partners,  L.P.,
                                          and   the   investment   manager   for
                                          Cerberus Institutional Partners, L.P.,
                                          Cerberus  International, Ltd. and  the
                                          Funds



      Attention: Intentional misstatements or omissions of fact constitute
                Federal criminal violations (See 18 U.S.C. 1001).